ENXTPA:ABVXBiotechs
ABIVAX (ENXTPA:ABVX) Q1 Loss Of €48.5 Million Tests Bullish Growth Narratives
ABIVAX Société Anonyme (ENXTPA:ABVX) opened Q1 2026 with revenue of €1.3 million and a loss of €48.5 million, equivalent to EPS of €0.61. This sets a clear picture of a business still investing heavily for future potential rather than current profitability. Over recent quarters, the company has reported revenue between €0.6 million and €4.3 million, while quarterly EPS ranged from €0.61 to €2.10 and quarterly net losses moved between €39.4 million and €153.4 million. This gives investors a...